Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.334 EUR | +1.83% | +7.05% | -16.71% |
Mar. 11 | Biofrontera Files Prospectus for Potential Secondary Stock Offerings | MT |
Mar. 05 | Medicus Pharma Names COO | MT |
Business Summary
Number of employees: 92
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical and Medical Products
100.0
%
| 29 | 100.0 % | 26 | 100.0 % | -10.59% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
66.6
%
| 20 | 70.3 % | 17 | 66.6 % | -15.19% |
Germany
18.5
%
| 5 | 18.3 % | 5 | 18.5 % | -9.50% |
Europe
13.6
%
| 3 | 11.4 % | 3 | 13.6 % | +6.94% |
Other Regions
1.3
%
| - | - | 0 | 1.3 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 55 | 22-09-11 | |
Anke zur Muehlen
IRO | Public Communications Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 63 | 21-12-13 | |
Director/Board Member | - | 21-12-13 | |
Heikki Lanckriet
BRD | Director/Board Member | 47 | 21-12-13 |
Helge Lubenow
BRD | Director/Board Member | 56 | 21-12-13 |
Director/Board Member | 65 | 22-08-22 | |
Jörgen Thielmann
BRD | Director/Board Member | - | 21-12-13 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 3,038,431 | 984,451 ( 32.40 %) | 0 | 32.40 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
BIOFRONTERA INC. 7.86% | 400,000 | 7.86% | 616,000 $ |
Company contact information
Sector
Sales per region
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-18.20% | 22.42M | |
+24.91% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.80% | 233B | |
+5.75% | 201B | |
-10.22% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- B8F Stock
- Company Biofrontera AG